In September 2012, BC Partners acquired Aenova. Aenova is now the #1 European and #3 worldwide CDMO and provides product development and manufacturing services for pharma / consumer healthcare customers.

The company offers solid, semi-solid and liquid dosage forms with leading positions in attractive technologies and markets, including solids, softgel caps, sterile and special substances and animal health.

In April 2024, BC Partners sold a majority take in Aenova to Kühne Holding AG.

 

Sector
Healthcare
Strategy
Private Equity
Investment year
2012
Region
Europe
Investment status
Realised

Our partnerships

At BC, we provide our portfolio companies with the access and expertise to scale into leading global businesses. We are a partner for growth.

See full portfolio